Descrizione Clinica
Stomach and intestine Mylicon bb os gtt 30ml Mylicon
MYLICON BAMBINI GOCCE ORALI SOLUTION
active ingredients
1 ml of solution contains Active ingredient: simeticone (dimethylpoxane activated) 66,6 mg For the complete list of excipients, see 6.1Excellent
Citric acid monohydrate; Sodium citrate; Metilidroxypropylcellulose; Carbossipolymethylene; Saccarina; Benzoate sodium; Sorbial acid; Sodium bicarbonate; Raspberry essence; Concentrated vanilla essence; Purified waterTherapeutic indications
Syntomatic treatment of gastro-enteric meteorism and infant aerophagia.Contraindications
Hypersensitivity to the active ingredient or any of the excipients Generally contraindicated in pregnancy (see paragraph 4.6)Population
Milking and children: 20 drops (= 0.6 ml), 2-4 times a day preferably after meals or otherwise by prescription. Shake well before use.Conservation
No special conditions of conservation are foreseenWarnings
Do not exceed the recommended doses. After a short period of treatment (7 days) without appreciable results consult your doctor.Interactions
They are not known, nor have they been reported, incompatibility with other drugs.Effects
Undesirable effects of Mylicon have not been highlighted.Overdosing
No overdose phenomena have been reported with the use of Mylicon. Pregnancy.
There is no adequate data on the use of Mylicon in pregnant women, so it should not be used in pregnancy unless a real need and after risk/benefit assessment by the doctor. Nursing.
It is not known whether symeticons are excreted in breast milk. The excretion of symeticons in breast milk was not studied in animals. The decision whether to continue/interrupt breastfeeding or continue/interrupts treatment based on semeticons should be taken taking into account the benefit of breastfeeding for the newborn and the treatment based on simeticons for women.
Source: Farmadati
